SAVA
Cassava Sciences Inc
Price:  
2.16 
USD
Volume:  
626,072.00
United States | Pharmaceuticals
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

SAVA Relative Valuation

-1418.4%
Upside

As of 2025-07-11, the Relative Valuation of Cassava Sciences Inc (SAVA) is (28.48) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.16 USD, the upside of Cassava Sciences Inc based on Relative Valuation is -1418.4%.

The range of the Relative Valuation is (27.42) - (28.02) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 17.9x - 18.6x 18.4x
Forward P/E multiples 18.2x - 20.7x 19.4x
Fair Price (27.42) - (28.02) (28.48)
Upside -1369.5% - -1397.4% -1418.4%
2.16 USD
Stock Price
(28.48) USD
Fair Price

SAVA Relative Valuation - Historical P/E Data

Date P/E
2025-07-10 -1.43
2025-07-09 -1.45
2025-07-08 -1.38
2025-07-07 -1.28
2025-07-03 -1.33
2025-07-02 -1.33
2025-07-01 -1.23
2025-06-30 -1.20
2025-06-27 -1.16
2025-06-26 -1.21
2025-06-25 -1.23
2025-06-24 -1.29
2025-06-23 -1.25
2025-06-20 -1.32
2025-06-18 -1.37
2025-06-17 -1.37
2025-06-16 -1.36
2025-06-13 -1.36
2025-06-12 -1.41
2025-06-11 -1.39
2025-06-10 -1.44
2025-06-09 -1.43
2025-06-06 -1.45
2025-06-05 -1.41
2025-06-04 -1.43
2025-06-03 -1.43
2025-06-02 -1.41
2025-05-30 -1.33
2025-05-29 -1.35
2025-05-28 -1.39
2025-05-27 -1.41
2025-05-23 -1.40
2025-05-22 -1.41
2025-05-21 -1.36
2025-05-20 -1.49
2025-05-19 -1.37
2025-05-16 -1.39
2025-05-15 -1.36
2025-05-14 -1.25
2025-05-13 -1.23
2025-05-12 -1.21
2025-05-09 -1.17
2025-05-08 -1.13
2025-05-07 -1.04
2025-05-06 -1.00
2025-05-05 -1.06
2025-05-02 -1.07
2025-05-01 -1.08
2025-04-30 -1.04
2025-04-29 -1.04